Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.

Magni R, Espina BH, Shah K, Lepene B, Mayuga C, Douglas TA, Espina V, Rucker S, Dunlap R, Petricoin EF, Kilavos MF, Poretz DM, Irwin GR, Shor SM, Liotta LA, Luchini A.

J Transl Med. 2015 Nov 4;13:346. doi: 10.1186/s12967-015-0701-z.

2.

Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.

Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, Bailer RT, Poretz DM, Sarwar U, Kabadi A, Koup R, Mascola JR, Graham BS; VRC 307 and VRC 309 Study Teams.

Contemp Clin Trials. 2015 Sep;44:112-118. doi: 10.1016/j.cct.2015.08.006. Epub 2015 Aug 12.

3.

Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.

Mullane KM, Winston DJ, Wertheim MS, Betts RF, Poretz DM, Camacho LH, Pergam SA, Mullane MR, Stek JE, Sterling TM, Zhao Y, Manoff SB, Annunziato PW.

J Infect Dis. 2013 Nov 1;208(9):1375-85. doi: 10.1093/infdis/jit344. Epub 2013 Aug 1.

PMID:
23908479
4.

Clarification of the Agreement between the Infectious Diseases Society of America and the Attorney General of Connecticut.

Poretz DM.

Clin Infect Dis. 2008 Nov 1;47(9):1200. doi: 10.1086/592248. No abstract available.

PMID:
18823267
5.

It's Not Just the Hospital Anymore.

Poretz DM.

Curr Infect Dis Rep. 2003 Aug;5(4):277-278. No abstract available.

PMID:
12866977
6.

Outcomes of a trial of HIV-1 immunogen in patients with HIV infection.

Poretz DM.

JAMA. 2001 May 2;285(17):2192-3; author reply 2193-5. No abstract available. Erratum in: JAMA 2001 May 23-30;285(20):2582.

PMID:
11325315
7.

Outpatient management of infectious diseases.

Poretz DM.

Int J Clin Pract Suppl. 2000 Dec;(115):23-5. No abstract available.

PMID:
11219295
8.
9.

Evolution of outpatient parenteral antibiotic therapy.

Poretz DM.

Infect Dis Clin North Am. 1998 Dec;12(4):827-34. Review.

PMID:
9888024
10.

Outpatient parenteral antibiotic therapy.

Poretz DM.

Int J Antimicrob Agents. 1995 Jan;5(1):9-12.

PMID:
18611638
13.

Outpatient use of intravenous antibiotics. Introduction.

Poretz DM.

Am J Med. 1994 Aug 15;97(2A):1-2. No abstract available.

PMID:
8059795
15.

High tech comes home.

Poretz DM.

Am J Med. 1991 Nov;91(5):453-4. No abstract available.

PMID:
1951406
16.

Home intravenous antibiotic therapy.

Poretz DM.

Clin Geriatr Med. 1991 Nov;7(4):749-63. Review.

PMID:
1760792
17.

The infusion center: a model for outpatient parenteral antibiotic therapy.

Poretz DM.

Rev Infect Dis. 1991 Jan-Feb;13 Suppl 2:S142-6.

PMID:
2017641
18.

Home management of antibiotic therapy.

Poretz DM.

Curr Clin Top Infect Dis. 1989;10:27-42. Review. No abstract available.

PMID:
2679697
19.

Home management of intravenous antibiotic therapy.

Poretz DM.

Bull N Y Acad Med. 1988 Jul-Aug;64(6):570-6. No abstract available.

20.

Antibiotic therapy of osteomyelitis in outpatients.

Ingram C, Eron LJ, Goldenberg RI, Morrison AJ Jr, Poretz DM, Alder ME, Harvey LK, Rising JB, Sparks SB.

Med Clin North Am. 1988 May;72(3):723-38.

PMID:
3352376
21.

Pneumocystis carinii choroiditis in a male homosexual with AIDS and disseminated pulmonary and extrapulmonary P. carinii infection.

Macher AM, Bardenstein DS, Zimmerman LE, Steigman CK, Pastore L, Poretz DM, Eron LJ.

N Engl J Med. 1987 Apr 23;316(17):1092. No abstract available.

PMID:
3494199
22.

Eikenella corrodens cervical osteomyelitis: case report.

Peereboom D, Poretz DM.

Va Med. 1987 Mar;114(3):150-3. No abstract available.

PMID:
3300082
23.

Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria.

Eron LJ, Harvey L, Hixon DL, Poretz DM.

Antimicrob Agents Chemother. 1985 Aug;28(2):308-10.

24.

Intravenous antibiotic therapy in ambulatory pediatric patients.

Goldenberg RI, Poretz DM, Eron LJ, Rising JB, Sparks SB.

Pediatr Infect Dis. 1984 Nov-Dec;3(6):514-7.

PMID:
6514592
25.

Outpatient use of ceftriaxone: a cost-benefit analysis.

Poretz DM, Woolard D, Eron LJ, Goldenberg RI, Rising J, Sparks S.

Am J Med. 1984 Oct 19;77(4C):77-83.

PMID:
6093525
26.

Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings.

Eron LJ, Goldenberg RI, Poretz DM.

Am J Surg. 1984 Oct 19;148(4A):1-4.

PMID:
6091473
27.

Imipenem versus moxalactam in the treatment of serious infections.

Eron LJ, Hixon DL, Park CH, Goldenberg RI, Poretz DM.

Antimicrob Agents Chemother. 1983 Dec;24(6):841-6.

28.

Ceftriaxone therapy of serious bacterial infections.

Eron LJ, Park CH, Goldenberg RI, Poretz DM.

J Antimicrob Chemother. 1983 Jul;12(1):65-78.

PMID:
6311783
29.

Ceftazidime in patients with Pseudomonas infections.

Eron LJ, Park CH, Hixon DL, Goldenberg RI, Poretz DM.

J Antimicrob Chemother. 1983 Jul;12 Suppl A:161-9.

PMID:
6225762
30.

Piperacillin therapy for Pseudomonas infections.

Eron LJ, Goldenberg RI, Poretz DM, Park CH.

South Med J. 1983 Jul;76(7):859-62.

PMID:
6223378
31.

Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.

Eron LJ, Park CH, Hixon DL, Goldenberg RI, Poretz DM.

Antimicrob Agents Chemother. 1983 May;23(5):731-7.

32.

The private practice of infectious diseases.

Poretz DM.

J Infect Dis. 1983 Mar;147(3):417-21. No abstract available.

PMID:
6833790
33.

Home IV programs.

Poretz DM.

Cost Containment. 1983 Feb 22;5(4):3-4. No abstract available.

PMID:
10258194
34.

Ceftazidime therapy of serious bacterial infections.

Eron LJ, Goldenberg RI, Park CH, Poretz DM.

Antimicrob Agents Chemother. 1983 Feb;23(2):236-41.

35.

Intravenous antibiotic therapy in an outpatient setting.

Poretz DM, Eron LJ, Goldenberg RI, Gilbert AF, Rising J, Sparks S, Horn CE.

JAMA. 1982 Jul 16;248(3):336-9.

PMID:
7087128
36.

Outpatient IV therapy program decreases cost for hospitals.

Poretz DM.

Hosp Peer Rev. 1982 Jan;7(1):14-5. No abstract available.

PMID:
10253806
37.

Mycobacterium chelonei infects the maxillary sinus: a rare case.

Eron LJ, Huckins C, Park CH, Poretz DM, Gelman HK, Ball MF.

Va Med. 1981 May;108(5):335-8. No abstract available.

PMID:
7257552
38.

Treatment of Salmonella prostatitis with trimethoprim-sulfamethoxazole.

Young DV, Poretz DM.

South Med J. 1978 Jun;71(6):742-3. No abstract available.

PMID:
663711
39.

Erysipelothrix endocarditis with cutaneous lesion.

Park CH, Poretz DM, Goldenberg R.

South Med J. 1976 Aug;69(8):1101-3. No abstract available.

PMID:
986691
40.

Chronic meningococcemia.

Dineen JF, Poretz DM.

Va Med Mon (1918). 1975 Nov;102(11):957-8. No abstract available.

PMID:
1199416
41.

Intracranial suppuration secondary to trauma. Infection with Nocardia asteroides.

Poretz DM, Smith MN, Park CH.

JAMA. 1975 May 19;232(7):730-1. No abstract available.

PMID:
1091758
42.

The NBT test in bacterial and non-bacterial pharyngitis.

Poretz DM.

Va Med Mon (1918). 1974 Aug;101(8):653-6. No abstract available.

PMID:
4855171
43.

Microbial contamination of glass bottle (open-vented) and plastic bag (closed-nonvented) intravenous fluid delivery systems.

Poretz DM, Guynn JB Jr, Duma RJ, Dalton HP.

Am J Hosp Pharm. 1974 Aug;31(8):726-32. No abstract available.

PMID:
4604770
44.

Adenocarcinoma of the colon presenting as Clostridium septicum cellulitis of the left thigh.

Poretz DM, Wood L, Park C.

South Med J. 1974 Jul;67(7):862-4. No abstract available.

PMID:
4834747
45.

Use of amoxicillin in the treatment of urinary tract infections.

Miller GB Jr, Duma RJ, Middleton FG, Poretz DM.

J Infect Dis. 1974 Jun;129(0):suppl:S237-40. No abstract available.

PMID:
4601194
46.

Clinical and laboratory evaluation of amoxicillin (BRL 2333) in the treatment of urinary tract infections.

Middleton FG, Poretz DM, Duma RJ.

Antimicrob Agents Chemother. 1973 Jul;4(1):25-30.

47.

Growth of various bacteria in a variety of intravenous fluids.

Guynn JB Jr, Poretz DM, Duma RJ.

Am J Hosp Pharm. 1973 Apr;30(4):321-5. No abstract available.

PMID:
4633267

Supplemental Content

Loading ...
Support Center